Outcomes of untreated subclinical antibody-mediated rejection after heart transplantation

Jacinthe Boulet, Jane Kelleher, Mauro R.B. Wanderley, Anju Nohria, Charlotte Andersson, Miae Kim, Mandeep R. Mehra*

*Corresponding author af dette arbejde

Abstract

Subclinical antibody-mediated rejection (AMR) is represented by histopathological and/or immunopathological manifestations in the absence of significant cardiac allograft dysfunction. Treatment remains uncertain as there is a lack of data on asymptomatic heart transplant (HT) recipients (HTR) with a positive cardiac biopsy. We sought to determine the impact of untreated subclinical biopsy-proven AMR, regardless of circulating donor-specific antigen (DSA) expression, when diagnosed on surveillance biopsies in the first year after HT. This retrospective case control study evaluated 260 HTR between May 2004 and February 2021. These comprised 231 controls and 29 patients with untreated subclinical AMR. The mortality event rate was higher in controls (2.63 events per 100 person-years) compared to the scAMR Group (1.71 events per 100 person-years), a difference that did not reach statistical significance (hazard ratio 0.66, CI: 0.18–2.36). The combined event rate of cardiac allograft vasculopathy (CAV), graft dysfunction, or mortality was higher in the subclinical AMR group (5.60 events per 100 person-years) than in controls (3.89 events per 100 person-years) but did not reach statistical significance (hazard ratio 1.63, CI: 0.07–40.09). Our results suggest that subclinical AMR diagnosed in the first year after HT on surveillance biopsy is not associated with decreased survival. This may sway the management of subclinical AMR towards a more conservative approach in transplant-capable institutions that currently prioritize treatment, though prospective, randomized studies of such a management strategy are required.

OriginalsprogEngelsk
TidsskriftProgress in Cardiovascular Diseases
Vol/bind81
Sider (fra-til)48-53
Antal sider6
ISSN0033-0620
DOI
StatusUdgivet - 1 nov. 2023
Udgivet eksterntJa

Fingeraftryk

Dyk ned i forskningsemnerne om 'Outcomes of untreated subclinical antibody-mediated rejection after heart transplantation'. Sammen danner de et unikt fingeraftryk.

Citationsformater